FIELD: medicine, gastroenterology. SUBSTANCE: as a medicinal preparation one should apply Pro-Gly-Pro tripeptide to be introduced either intraperitoneally at the quantity of 1.0- 1.25 mg/kg or perorally at the quantity of 0.1-0.9 mg/kg. EFFECT: higher efficiency of prophylaxis and therapy. 5 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT FOR PROPHYLAXIS AND TREATMENT OF GASTROENTERIC TRACT ULCERS, METHOD OF TREATMENT AND METHOD OF PROPHYLAXIS OF GASTROENTERIC TRACT ULCERS | 2001 |
|
RU2191593C1 |
METHOD FOR PREVENTING AND TREATING ULCERS OF GASTRO-INTESTINAL TRACT | 2003 |
|
RU2252779C1 |
ADMINISTRATION OF Pro-Gly-Pro PEPTIDE AS INTRANASAL AGENT IN PREVENTION AND TREATMENT OF GASTRIC ULCER IN RATS | 2009 |
|
RU2414923C1 |
PHARMACOLOGICAL AGENT FOR THE TREATMENT OF GASTRIC ULCER | 2018 |
|
RU2688187C1 |
METHOD FOR PREVENTING AND TREATING GASTRIC ULCER CAUSED BY ADMINISTRATION OF ETHANOL LIQUIDS | 2013 |
|
RU2527334C1 |
METHOD OF TREATING DIABETES IN ANIMALS | 2009 |
|
RU2403910C1 |
METHOD FOR PREVENTION OF ULCERATION OF GASTRIC MUCOSA | 2020 |
|
RU2744455C1 |
METHOD OF GASTER ULCER TREATMENT IN EXPERIMENT | 1992 |
|
RU2057530C1 |
PHARMACOLOGICALLY ACTIVE SUBSTANCE OF ORGANISM-PROTECTION MATERIAL, METHOD OF PREPARATION THEREOF, AND THERAPEUTIC APPLICATION | 1990 |
|
RU2104704C1 |
METHOD OF STOMACH AND DUODENUM ULCER TREATMENT | 2007 |
|
RU2357741C1 |
Authors
Dates
2003-11-27—Published
2002-08-12—Filed